As a mage, I just want to pursue the truth

Chapter 31 Body, Soul and Memory

Zheng Li usually takes a walk around the public experimental area in the morning, listens to everyone's questions, and offers some ideas.

Then he went back to the 17th floor where he was the only one there. Besides him, there were only different kinds of experimental animals on the 17th floor.

The mainstream biological experimental animals are generally mice, and there are some more common ones, such as macaques, gorillas, dogs, rabbits, etc.

Cows and sheep are less common in experiments, but sheep are the most famous. The first cloned animal was Dolly the sheep.

The largest number of animals in Zheng Li's laboratory are mice, and the largest area is occupied by macaques.

With the rapid growth of domestic biomedical research and development and the continuous improvement of domestic new drug safety assessment requirements, the number of monkeys required for preclinical research has increased year by year.

In addition, experimental monkeys are highly susceptible to the epidemic due to their high genetic homology with humans, making them the most effective experimental animal subjects after an epidemic occurs.

The price of experimental monkeys has skyrocketed, with the domestic price rising from 60,000 yuan per monkey at the beginning of the year to nearly 100,000 yuan per monkey now.

It is even more expensive in Singapore, where a laboratory monkey generally costs NT$120,000.

In the previous verification phase, mice were used to implant the most basic magic brain into their bodies. This most basic magic brain can only enable creatures to influence reality through instinct, but it cannot accurately turn what you want into reality.

Just like you can’t use the most basic magic brain to achieve the level 0 magic hand trick in the DND system.

When the mage was first born, he always believed that humans have souls, and later he developed the belief that all intelligent life forms have souls.

But for a long time the wizards had no way to verify this view, just as humans used to believe in the existence of God but could not verify it.

As time went on, mages directly observed the existence of the soul through research.

Later, the mages discovered that memory, soul and body are the components of intelligent life.

To describe it using the computer system familiar to Blue Star, the body is the hardware, the soul is the middleware, and the memory is the system and software.

This groundbreaking discovery was made after mages developed space teleportation. They found that it was possible to teleport objects, but if the object being teleported was an intelligent creature, it could only act according to instinct after being teleported.

The wizard therefore seriously suspected that teleportation caused intelligent creatures to lose their souls, and later successfully proved this.

Until the time Zheng Li came to Blue Star, the magician still had not figured out a way to teleport the soul, body, and memories together.

The soul, memory, and body are like an impossible triangle. When a space jump occurs, only two of the three can exist.

In other words, in Blue Star’s time-travel novels, it is possible to travel through time through the soul, but not through time through time through the flesh.

In addition, the matching degree between the soul and the magic brain is directly related to the spellcasting ability. The Mage Alliance will give out standard magic brains, but some people will choose to go to specialized institutions to customize magic brains.

The reason why Zheng Li needs experimental monkeys is because monkeys are also intelligent creatures and they also have souls.

In order to match the artificial magic brain and the soul, he needed to conduct experiments on experimental monkeys.

The research and development of artificial magic brains is lengthy and tiring, but fortunately there are accurate goals and perfect theoretical support so that people do not lose confidence and fighting spirit.

(The specific experimental steps are a bit disgusting, so I won’t write them. I was disgusted after writing 500 words, so forget it.)
Simply put, the embryonic magic brain is implanted into the embryo of the mother monkey, the embryo that has not yet fully formed but has already produced a soul is taken out, and then the degree of matching is observed through a specific device. Finally, the embryo is processed.

At the beginning of 2021, one year has passed since the outbreak of the epidemic, and the epidemic has not improved at all. To be precise, the situation has not improved worldwide, but has become more and more serious.

The global demand for endorphins continues to grow. Previously, the period for Ke Chuang Biotechnology to license its technology to other companies was five years. Even after licensing it to other companies, endorphins are still in short supply.

Because alpha-endorphin reduces the addictiveness of opioids, the number of people buying endorphins has increased significantly, and Canada Mathematics University was the first to announce that it would provide endorphins free of charge to "addicts" to reduce their addiction to drugs.

Some European countries and Australia followed suit, which led to further growth in the demand for endorphins.

Since endorphins need to be combined with lipotropin peptides to exert their addiction-reducing effects, the demand for lipotropin peptides has been growing.

The management of Sinovation Biopharma does not want to see the market occupied by other authorized pharmaceutical companies, so they also want to expand the production of endorphins.

The annual output of endorphins at the Suzhou production base is now about 16000L, which has doubled from the middle of the year.

After the Lion City R&D center was put into use, the money on Kechuang Bio's books was spent like water.

The small shareholders of CStone Bio all hope that CStone Bio will start the next round of venture capital, while the management of CStone Bio hopes to go public directly.

Because they can only get options and achieve financial freedom after Ke Chuang Bio goes public, it is highly likely that there will not be a special option pool for the management if Ke Chuang Bio invests in its C round of venture capital.

Zheng Li does not want to further dilute his shares in Kechuang Bio. If he conducts another round of venture capital, his equity will most likely drop below 50 percent by the time the company goes public.

A drop below 50% means that Ke Chuang Bio is no longer his one-man show. If Magic Brain does not make any progress, his days may not be as easy as they are now.

"If we want to go public, it would be best to list on the A-share market. Listing on the U.S. stock market under the current circumstances may not be a good thing," said Li Miaomiao.

Zheng Li nodded: "You guys discuss these things first, come up with a plan and then report to me."

After Kechuang Biotechnology announced its plan to go public, major securities firms came to Kechuang Biotechnology's door.

Let’s put it this way. In 2020, a total of 145 companies were listed on the Science and Technology Innovation Board, and these companies raised a total of 2226.22 billion RMB in funds.

The valuation of Kechuang Bio is about 1200 billion RMB, and the funds raised are at least 720 billion RMB.

This is because the Science and Technology Innovation Board must issue at least 10 percent of its shares.

After Endorphin was listed in China, Kechuang Bio has been hailed as the largest unicorn company in China. The purpose of this listing is to expand the production scale of Endorphin.

This is a business that is sure to make money for securities firms. For the investment banking department of a securities firm, the science and technology innovation and biotechnology business can meet the full-year performance targets.

Is there anything better than completing the entire year’s marketing at the beginning of the year?

Apart from CITIC and CITIC Construction Investment, Suzhou-based Soochow Securities is the most active.

Small brokerage firms generally don't stand a chance with an IPO of this scale, but Soochow Securities is relying on its headquarters in Suzhou to try to take over an elephant.

(End of this chapter)